Laddar...
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease
Mycobacterium avium complex is now the leading mycobacterial cause of chronic pneumonia in the United States. Macrolides and ethambutol form the backbone of the regimen used in the treatment of pulmonary disease. However, therapy outcomes remain poor, with microbial cure rates of 4% in cavitary dise...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Microbiology
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808200/ https://ncbi.nlm.nih.gov/pubmed/26810646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02854-15 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|